Leica Biosystems Bond Oracle HER2 IHC System - Инструкция (Страница 25)

Стр. 25 из 25
Pу
сский
Leica Biosystems Bond Oracle HER2 IHC System Инструкции по эксплуатации TA9145 RU-CE-Rev_E 18/06/2013
Pу
сский
4. Hudziak RM, Lewis GD, Winget M, Fendly BM, Shepard HM, Ullrich A. p185HER2 monoclonal
antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor
necrosis factor. Molecular & Cell Biology 1989; 9: 1165-72.
5. Lewis GD, Figari I, Fendly B, Wong WL, Carter P, Gorman C, et al. Differential responses of human
tumor cell lines to anti-p185HER2 monoclonal antibodies. Cancer Immunology and Immunotherapy 1993; 37: 255-63.
6. Baselga J, Norton L, Albanell J, Kim Y-M, Mendelsohn J. Recombinant humanized anti-HER2
antibody (Herceptin ® ) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/
neu overexpressing human breast cancer xenografts. Cancer Research 1998; 58: 2825-31.
7. Nakane PK and Pierce GB. Enzyme labeled antibodies: Preparations and applications for the
localization of antigens. Journal of Histochemistry and Cytochemistry. 1967; 14: 929-931.
8. Tsutsumi Y, Serizawa A and Kawai K. Enhanced polymer one-step staining (EPOS) for proliferating
cell nuclear antigen and Ki-67 antigen-applications to intraoperative frozen diagnosis. Pathology
International . 1995; 45(2): 108-115.
9. Walker RA, Bartlett JMS Dowsett M, Ellis IO, Hanby AN, Jasani B, Miller K and Pinder SE. HER2
Testing in the UK- Further Update To Recommendations. Journal of Clinical Pathology 2008
10. Dickson, RB and Lippman, ME. Genes, Oncogenes, and Hormones. Boston, Kluwer Academic Publishers, 1992.
11. Keatings, L. et al. c-erbB-2 oncoprotein expression in mammary and extramammary Paget’s
disease: an immunohistochemical study. Histopathology. 1990; 17: 234-247.
12. The National Committee for Clinical Laboratory Standards (NCCLS). Quality assurance for immunocytochemistry;
Approved guideline. NCCLS document MM4-A (1-56238-396-5) NCCLS, 940 West Valley Road, Suite
1400, Wayne, Pennsylvania 1999; 19087-1898: USA
13. Elias JM, Gown AM, Nakamura RM, Wilbur DC, Herman GE, Jaffe ES, et al. Special Report:
Quality control in immunohistochemistry. American Journal of Clinical Pathology 1989 ;92: 836-43.
14. Press MF, Cordon-Cardo C, Slamon DJ. Expression of the HER-2/neu proto-oncogene in normal
human adult and fetal tissues. Oncogene 1990; 5: 953-62.
15. Nadji, M. and Morales, A. R. Immunoperoxidase, part I: the techniques and its pitfalls. Laboratory
Medicine 1983; 14: 767.
16. Jackson P. 2007. Quality Assurance in Immunohistochemistry. In: Immunohistochemistry, 2007 (ed.
Renshaw S), PP 205-237. Scion Publishing Ltd.
17. Omata M, Liew C-T, Ashcavai M, Peters RL. Nonimmunologic binding of horseradish peroxidase
to hepatitis B surface antigen: a possible source of error in immunohistochemistry. American Journal of
Clinical Pathology 1980; 73: 626-32.
18. Bartlet JMS, Ibrahim M, et al External Quality Assurance of HER2 FISH Testing: Results of a UK
NEQAS Pilot Scheme. Journal of Clinical Pathology. 2006.
Изменения и дополнения к предыдущему изданию
Добавление символов.
Дата издания
18 Июнь 2013
Значение символов
LOT
Код партии Хранение
REF
№ каталога
IVD
Медицинский
прибор для
диагностики in vitro Изготовитель Хрупкое изделие
См. Инструкции по
использованию Содержит достаточно
для <n> исследований Использовать до ГГГГ-MM-ДД
SN Серийный номер
HercepTest
™
– торговая марка лицензий компании DakoCytomation, Denmark A/S Herceptin
®
– торговая марка Genentech, Inc. и F. Hoffmann-La Roche Ltd.